Overview
- The nearly three-hour documentary earned about $15 million in a limited North American release on roughly 850–855 screens and sold out thousands of showings, making it one of the biggest limited openings for a non‑fiction film in decades.
- Directors Nathan Fielder and Lance Oppenheim filmed with Elizabeth Holmes in the weeks before she began an 11‑year federal sentence, living for a period in the family’s rented San Diego home to capture unusually embedded access.
- A24 has submitted the film in multiple Academy Award categories, including documentary feature, directing and Best Picture consideration, fueling early Oscar conversation and plans to expand the theatrical run.
- Coverage has shifted to ethical questions about the film’s methods and control of Holmes’ public story, with former Theranos whistleblower Tyler Shultz saying Holmes appears on‑screen as a victim in a controlling relationship while still insisting she knowingly lied about Theranos.
- The film’s success has reopened public focus on Theranos’ real‑world harms and raised broader industry questions about how formal experimentation in documentaries affects truth, accountability and awards norms.